Company
Bioverativ Inc. (0001681689)
Standardized SEC financial data for Bioverativ Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001681689 · Pharmaceutical Preparations.
Gross margin
71.9%
Operating margin
52.8%
Net margin
12.8%
Revenue growth (YoY)
52.8%
Return on equity
12.1%
Free cash flow
$577.6M
Current ratio
2.00×
Ratios for fiscal year 2016, standardized from SEC filings.
Income statement
| USD | FY2016 | FY2017 |
|---|---|---|
| Revenue | $846.6M | — |
| Cost of revenue | $237.9M | $279.6M |
| Gross profit | $608.7M | — |
| R&D expense | $210.1M |
Balance sheet
| USD | FY2016 | FY2017 |
|---|---|---|
| Cash & equivalents | — | $436.5M |
| Inventory | $302.0M | $40.6M |
| Total current assets | $475.6M | $778.3M |
| Property, plant & equipment | $28.4M |
Cash flow
| USD | FY2016 | FY2017 |
|---|---|---|
| Operating cash flow | $301.6M | $590.7M |
| Capital expenditures | $8.7M | $13.1M |
| Free cash flow | $292.9M | $577.6M |
| Investing cash flow | -$35.2M |
Get 0001681689 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001681689/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001681689/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"